NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-37.0%
5Y CAGR-16.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-37.0%/yr
Annual compound
5Y CAGR
-16.7%/yr
Recent deceleration
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.26M | -31.3% |
| 2024 | $6.20M | -53.6% |
| 2023 | $13.37M | -21.5% |
| 2022 | $17.03M | -15.9% |
| 2021 | $20.26M | +90.7% |
| 2020 | $10.63M | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |